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A physical model is described for the simultaneous enzymatic biocon- 
version of a nonelectrolyte solute and the passive transport of both the 
solute and product of the enzymatic reaction out of cells in culture suspen- 
sion. The plasma membrane is assumed to be the rate-determining trans- 
port barrier. This model provides the basis for the experimental design and 
analysis of the Michaelis-Menten kinetic parameters of simple enzymatic 
reactions in situ, the phenomenological transport parameters and other 
factors. The primary set of differential equations describing the quasi- 
steady state rate of change in the concentration of the solute and product 
within the cell due to enzyme reaction and transport are given. These are 
nonlinear and must be solved by numerical methods. However, analytical 
mathematical expressions have been derived for various cases in the limit 
when the rate of enzymatic reaction is first or zero order. 
1. Introduction 
The ultimate goal of bioavailability studies is to understand the mechanisms 
of drug action in the whole organism. Metabolism is an important component 
in this larger problem because the rates of synthesis (from a prodrug) or 
degradation of an active drug species affects the time course of the pharm- 
acological response. Unfortunately, the study of the time course of the drug 
and its metabolites in the whole organism does not yield some of the finer 
mechanistic detail that might be useful in designing a more effective drug or 
a more efficient drug delivery system. The use of purified enzymes and tissue 
homogenates in in vitro systems does yield a wealth of information at the 
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mechanistic level, however, one is never quite sure how many artifacts were 
introduced by the experimenter. The use of intact human cells in culture 
suspension, while not completely free of possible artifacts, offers a number of 
distinct advantages over the use of the latter in vitro systems. 
In such a system, the transport of the drug molecule through the plasma 
membrane and the intracellular rates of enzyme catalysis can be studied and 
correlated to a cellular pharmacological response. It is the determination of 
the intracellular rates of metabolism that are especially interesting since in 
the cell culture system they are modulated by a set of physical parameters 
native to the intact viable cell and not an artificial set imposed by the 
experimenter. 
Many times in the past (in in vivo and in vitro studies) the metabolic rate 
of synthesis of a substance has been confused with the rate of incorporation 
of a given precursor into the substance in question (Dietschy, 1970; 
Plagemann & Erbe, 1972). If one is intent on determining the rate constants 
for the metabolism of a drug, Dietschy (1970) has pointed out the importance 
of recognizing such factors as (1) the rate of penetration of a drug through 
the plasma membrane, (2) the existence of intracellular pools of the drug, 
and (3) the existence of intermediate compounds between the drug and its 
final product. Of course, if the drug is not endogenous, the situation is 
greatly simplified. A number of authors have qualitatively treated the 
problem of simultaneous transport and biosynthesis. 
Plagemann & Erbe (1972) have cited several authors (Smets, 1969;. Fuchs 
& Kohn, 1971) who found that the rate of thymidine incorporation into 
deoxyribonucleic acid (DNA) in cells does not accurately reflect the rate of 
DNA synthesis. One possible reason for this discrepancy is that the rate of 
uptake of the precursor into the cell is rate limiting for its incorporation into 
the macromolecule in question (Plagemann & Roth, 1969; Plagemann, 1971; 
Plagemann & Erbe, 1972). In the case of Novikoff hepatoma cells in sus- 
pension, both a diffusional and a Michaelis-Menten transport system 
appear to be possible mechanisms which govern uptake. When the con- 
centrations of thymidine are low, the Michaelis-Menten transport system is 
the relevant mechanism which limits the rate of incorporation of thymidine 
into DNA. Plagemann & Estensen (1972) have found that cytochalasin B 
affects this transport system but does not affect the rate of DNA and 
ribonucleic acid (RNA) synthesis from thymidine and uridine respectively. 
Jenden & Bassham (1968) and Duckworth (1970) have examined the 
simultaneous transport of precursors and the biosynthesis of macromolecules 
in isolated chloroplasts and E. coli B, respectively, in suspension systems. 
The authors, however, did not attempt to determine the limiting step in the 
incorporation of the precursors into the macromolecule. For a more 
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quantitative evaluation of the data, the problem of simultaneous transport 
and biosynthesis must be treated mathematically. 
Any mathematical treatment of the cell which allows for the transport of 
the substrate and the enzymatic reaction of the substrate inside the cell must 
be of sufficient symmetry that the mathematical analysis of the system is 
tractable; a spherically symmetric model of the cell is the simplest and yet 
experimentally one of the most accessible geometrical configurations that 
has been studied thus far. 
Rashevsky (1948) used Fick’s law for diffusion to model the metabolizing 
spherical symmetric cell assuming steady state. Using this assumption, he 
was able to derive an expression for the total diffusional resistance of the 
cell and the radial concentration profiles of the substrate inside and outside 
of the cell. Hearon (1953) generalized Rashevsky’s treatment to the situation 
when the rate of metabolism need not be the same at every point in the cell. 
Since actual Michaelis-Menten kinetics will be bounded by zero order 
(Rashevsky, 1948) and first order (Hearon, 1953) metabolism kinetics, Blum 
& Jenden (1957) expanded the source factor for the Michaelis-Menten rate 
of metabolism in a Taylor series in order to treat the intermediate range of 
concentrations. Because of experimental difficulties, earlier workers such as 
Best (1960) preferred to measure the change in the substrate level in the 
external fluid and not in the cells for an uptake experiment. Clearly the cell 
fraction would be more sensitive, analytically, for this purpose if one can 
remove the cells from the suspension and quench the metabolism. When the 
partitioning of the substrate into the cells is very small compared to the fluid 
fraction, it is mandatory to assay the cell fraction. The major assumption 
that Best (1960) and Blum & Jenden (1957) made in deriving expressions for 
the evaluation of the diffusional and biosynthetic parameters from the 
experimental data was that the rate of conversion of the substrate by the 
enzyme was the same as the rate of penetration of the substrate into the 
cell. While this was true for the substrates that Best (1960) studied, it is 
entirely conceivable that some substrates are metabolized slower or faster 
than they are transported into the cell’s interior milieu. Thus while the steady 
state assumption leads to mathematical simplicity it is possible that it cannot 
be justified for every substrate. The quasi-steady state formulation on the 
other hand, which follows, is not restricted in this way. 
In the first paper of this series, physical models for the diffusional transport 
of nonelectrolyte solutes across membranes of cells in suspension were 
introduced (Ho, Turi, Shipman & Higuchi, 1972). Following the quasi- 
steady state flux of drug across the plasma membrane, the distribution of 
drug in the cell interior was postulated to follow one of three principal models : 
(a) nonsteady state distribution in the heterogeneous cell interior, (b) rapid 
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(instantaneous) equilibration in the heterogeneous cell interior and (c) rapid 
(instantaneous) equilibration in the aqueous environment with slow simul- 
taneous permeation of drug into the cytoplasmic bodies and nucleus. 
Subsequently, experimental baseline studies on the uptake and release of 
various sterols and cardiac glycosides using Burkitt lymphoma cells in 
culture suspension at pH 7.3 under iso-osmotic conditions have been 
successful in gaining a physicochemical and quantitative understanding of 
the factors involved in the transport of these solutes (Turi, Higuchi, Shipman 
& Ho, 1972; Turi, 1972; Turi, Higuchi, Ho & Shipman, 19753). The second 
of the above three models was the one found to be in good agreement with 
the above experimental data, i.e. the rate-determining barrier to the passive 
transport of the sterols and cardiac glycosides appear to be the plasma 
membrane and not the stagnant aqueous layer about the cell nor the mem- 
branes of the cytoplasmic bodies and nucleus within the cell. Furthermore, 
variations of this model were derived to include the simultaneous binding of 
the drug to serum in the external media and to the outermost surface of the 
cell membrane, and the transport of the unbound drug into the cell (Turi, 
Ho, Higuchi & Shipman, 1975~). 
Next in the order of complexity of drug transport models across cell 
membranes, the simultaneous passive transport and bioconversion of a 
solute is presented. Again, the model is mathematically described in such a 
manner so that meaningful baseline experiments can be designed, and 
physical transport and chemical kinetic parameters are experimentally 
accessible. 
2. General Description of the Model 
A physical chemical model is developed which simultaneously accounts 
for solute diffusion, biosynthesis, and adsorption onto intracellular organelles 
in culture suspensions of mammalian cells. Figure 1 is a schematic diagram 
of a cell with the solute interactions indicated. 
The diffusion of the substrate Di and the product Ci out of the cell (Ho, 
Turi, Shipman 8z Higuchi, 1972) is given by the following expressions 
(1) 
(2) 
where Di and Ci are the total concentration of D and C, the substrate and 
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FIG. 1. Schematic model for simultaneous biosynthesis and transport. Substrate D, 
is enzymatically converted to product Ct and both are transported passively out of the cell. 
product respectively, inside the cell; D, and C,, are the total concentrations 
of D and C, respectively, in the bulk aqueous phase outside of the cell; PD 
and PC are the permeability coefficients of D and C respectively, &, and 
Kc are their partition coefficients,? a is the radius of the cell, and the 
factor 3/a represents the surface area to volume ratio per cell taken as a 
sphere. 
Equations (1) and (2) are based on three important assumptions. First, 
it is assumed that there is a rapid equilibrium within the cell’s heterogeneous 
interior with respect to the compounds to be studied so that the unbound 
fraction of these compounds is homogeneously distributed throughout the 
interior of the cell at all times. Next, it is assumed that the permeability of 
the plasma membrane is the rate determining step for the diffusion of the 
compounds out of the cell. Only nonelectrolytes are considered and no 
active transport is assumed to take place. The unbound solute is assumed to 
be the principal membrane-permeable specie. Experimental agreement with 
the model seems to indicate that these are valid assumptions for some sterols 
and cardiac glycosides (Turi, Higuchi, Shipman & Ho, 1972; and Turi, 
1972). The final assumption is that the flux across the plasma membrane is a 
Tin the situation where there is serum binding of D and C in the bulk aqueous phase 
outside of the cell, P and K become effective parameters (Turi, Higuchi, Shipman and Ho, 
1972). 
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quasi-steady state flux. This means that the concentration gradient across 
the plasma membrane is the same as that which would occur if steady-state 
were maintained. This is usually the case with thin membranes like the 
plasma membrane. 
The biosynthesis of Ci from Di is assumed to follow the classical one 
substrate Michaelis-Menten kinetics given by 
dD. -2 Vndi =--- 
dt K,+Di * (3) 
Although the biosynthesis of Ci from Di may, in fact, follow a more complex 
mechanism, it is assumed that it follows the same form of the above rate 
equation. Two other important assumptions must be made with regard to 
the applicability of equation (3) to the intracellular milieu. These assumptions 
are that a dynamic quasi-steady state situation exists within the cell with 
respect to the substrate and product, and that the possible allosteric trans- 
formations and regulatory interactions within the cell are such so as to 
maintain a constant specific activity of enzyme with respect to the substrate 
concentration. 
As a further simplifying approximation, equation (3) assumes that the 
total solute inside the cell, Di, is the substrate for enzymatic conversion, and 
therefore, it does not discriminate as to whether the relevant substrate is the 
free or a specific protein-bound solute among the other bound solute species. 
In fact, one would be experimentally hard pressed to elucidate such details. 
In the event that the unbound solute, Di, /, is the relevant substrate, then 
equation (3) should be rewritten as 
dDi f VmaxDi f -----L=d- 
dt Km+Di,/ ’ 
Here the mass balance can be expressed by 
Di = Di, / + C njkd, jDi, f j 
(4) 
where k,,,, j is the linear adsorption constant for the jth kind of absorbent 
(e.g. a mitochondria, nuclear membrane, endoplasmic reticulum, etc.) 
assuming a Langmuirian isotherm in the linear region with respect to solute 
concentration, and where nj is the number of adsorbents of the jth kind. 
Consequently, in terms of Dip equation (4) is equivalent to 
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Coupling equations (1) and (2) to (3) for the simultaneous diffusion of the 
compounds out of the cell and for the biosynthesis of C from D, we have 
dCi 3P, -- 
dt =a 
The mass balance equations are: 
(7) 
TD= DoVo+nViDi (9) 
Tc = C~V~+nViC'i (10) 
T = T,+T, (11) 
where Vi is the cell volume of an essentially monodispersed cell size dis- 
tribution, n is the number of cells, V, is the external bulk aqueous phase 
volume, and TI, and T, are the total amount of D and C, respectively, in the 
system. If T is conserved, then an important relationship for tracer studies 
is that the decrease in the total concentration of D in the closed system with 
time is related to the bioconversion of Di to Ci within the cell; i.e., 
1 dT, vma Ji --- -=- 
V dt K,+Di (12) 
where V = nVi+ V,. 
The initial boundary conditions for this model are: 
Ci = C,(O) 
Di = Di(0) 
TD = T'(O) 
Tc = T,(O) 
C,(O) = 0 
D,(O) = 0 
Equations (7), (8), and (12) form a set of nonlinear differential equations 
describing the quasi-steady state rate of change in the concentration of the 
drug and product within the cell due to enzyme reaction and transport. They 
can be solved by numerical methods. In order to gain a more explicit and 
helpful insight into the immediate treatment and interpretation of experi- 
mental data, we seek approximate, but analytic, solutions to the above 
primary set of differential equations. 
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3. Case I-Linear Approximation to Biosynthesis 
Consider the situation when Ci and D, are free to diffuse out of the cell, 
and the biosynthesis of Ct from D, occurs in the limit K,,, B Di. Consequently, 
equations (7), (8), and (12) become 








As shown in Appendix A, the solutions are: 
TD = Cl er2’+C2 e’2’ 
D,= - 
$yc 
lrl e”’ + C,r, erzt] 
and 






m  0 D 
3pDv vmax a=- -* 
av, * K, 
(20) 
(21) 
The constants E, y, 6, and 6, are defined in Appendix A. The constants C1, 
C,, and C3 can be determined from the initial conditions and are given by 
equations (A13), (A14) and (A15) in Appendix A. It is noted that the 
constants CI, /.I, E, y, C1, C, and C, are positive quantities. In contrast, y1 
and r2 are negative quantities such that lrzl > jr, I. 
The fundamental kinetic parameter v,,,,,/K,,, can be determined from 
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The permeability coefficients of the plasma membrane, PD and PC, and the 
partition coefficients, KD and Kc, can be determined from independent 
experiments with solutes D and C. For example, experiments involving the 
release of solute D from cells or its uptake by the cells in which various 
experimental conditions are imposed to prevent bioconversion reactions 
would result in determining PO and KD (Turi, Higuchi, Shipman & Ho, 
1972; Turi, Higuchi, Ho & Shipman, 197%). 
4. Case II-Taylor Series Expansion of the Biosynthetic Factor 
The nonlinear factor in equation (3) may be expanded in a Taylor series 
about Di = Di(0) at t = 0. To the first order 
Therefore, equation (3) becomes 
where 
o = [Di(O) + KJ2 
so that equations (7), (8) and (12) become 
1 dT, 
7 dt 




Equations (25), (26) and (27) along with the mass balance equations 
describe the system. The solutions for TD and Di are: 
TD = B, eS1’+B2 eszr+E (28) 
Di = $~(B,s, eS”+B2s2 es”)-: (29) 
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s1,2 = -@k2/4-k’ 
k = 3p, nvil , 
a [ 1 
k, = 3pDvw’ 
aVo 
k” = 7;gi!!!!+k,), 
B, and B, are determined from the initial conditions and are described in 
Appendix B. It is noted that the constants w, w’, k, k’, B, and B, are positive 
quantities and the constants k”, S, and S2 are negative quantities such that 
IS21 > ISll. 
Two remarks are in order about the comparison of case I and case II. In 
case I, the limit of K,,, B Di allowed us to approximate equation (3) and the 
equations dependent on (3) by the term v,,,,,Di/Km. In case II equation (3) is 
approximated by w  + w’D,. But, in the limit as D,(O) tends to zero, it follows 
that w  and w’ tend to zero and v,,,,,/K,,,, respectively, and all of the constants 
of case II, such as si, 2, k, k’, etc., tend to their corresponding values as 
defined in case I. 
Finally, one notes that 
-.S1 [s,+L> (?+f,)l 





Since w’ by equation (24) is a function of vmax, K,, and Di(0), the theory 
implies that equation (30) determines v,,, and K,,, independent of equation 
(22), given Di(0) and si. 
5. Case III-Enzyme Saturation 
In this case, when Di Z+ K,,,, the substrate is in great excess of the enzyme 
concentration and equation (3) is approximated by v,,,. Thus, equations (7) 
(8) and (12) become 
1 dT,, 
7 --&-= -vmax 
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The solutions to this system of equations arc: 
TD = - vmaxVt + T,(cJ) 
Di = Al e-~t+v~~~~(l-pt)+b[~TD(0)-V,,.] 






where the constants p, ~1, $, and r$ are defined in Appendix C and A, and 
A, are determined from the initial conditions and are given by (C6) and (C7). 
APPENDIX A 
Case I-Linear Approximation to Biosynthesis 
The elimination of DO in equation (13) with (9) gives 
dD. 3P, -dy = a [2-(z+ij)Di] -zDi (Al) 
Using equation (15), we can express equation (Al) accordingly: 
d2To dT, 
-+P;--+aT, = 0 
where 





UV, K, * 
(A3 
The solution is 
where 
TD = C, e”‘+C, erzt G43) 
--__ 
r1,2 = -$ Jp,4-cl 
and C1 and C, are constants to be determined by the initial conditions. 
After differentiating equation (A3) and substituting into (15), we get 
Di = -+T [C,r, erlf+Ctr2 eQ’] 
max 
644) 
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To find Ci we start with equation (14) and eliminate C,, and Tc by using 
equations (10) and (11); thus, 
dCI 3Pc 
dt+a (A3 




x+yCi = &-Cl61 e’l’-C,S, e’“’ 646) 
y+ ( > $?+f 0 C 
3P,T EC- 
avo 
Equation (A6) is a nonhomogeneous linear differential equation with 
constant coefficients. The solution to the associated homogeneous differential 
equation is C, exp (- rt) and the particular solution is assumed to be of the 
form v&) exp (- yt). The general solution is expressed by 
and 




After combining equations (A6), (A7) and (A8) and then integrating, 










Equations (A3), (A4) and (AlO) form the solution set to the system of 
differential equations for this case. The constants C,, C,, C, can be 
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determined from the initial conditions : 
C, = Ci(0) 
4 = W) 
TD = T,(O) 
Thus, 
(A121 
c3 = %l,xv ~ -.-!L 62 
Kh - r2) ( r2+y rl+y > 
Q(O) +-Lx 
(rl - r2) 
x 
82r1 br2 ~- (r2+y) (II +r> T,(O) + Ci(0) -$s (Al 3) 
APPENDIX B 
Case II-Taylor Series Expansion of Equations (3) 
The derivation for this case exactly parallels that of case 1. Substituting 
equations (9) and (27) into (25), we obtain 
d2TD dT, 





k”= -WV{? E+-!-]} 
The solution to equation (Bl) is 
TD = B, e’*‘+B, eszt+F 
where 
s1.2 = -+k=/4-k’ 
W) 
WI 
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The combination of equation (27) and the derivative of (B2) leads to 
Di = -&(BlS, eS1’+B2s2 eszt)-,“; (B3) 












Case III-Enzyme Saturation 
Equation (33) can be directly integrated to give 
TD = - v,,,Vt + TD(0). 
Substituting in equations (9) and (Cl) into (31) gives 
dD, 




p = ?5 nv; 1 
a ( > v-- +c 0 D 
p=$. 
0 
The solution to (C2) can be found by the method of variation of parameters 
as in Appendix A. The solution is 
Di = A, e-nz+5~f’(l -pt)+i[pTD(0)-v,,,,J . (C3) 
Similarly equation (32) becomes 
dCi 
dr+$Ci = v,,,+~[T-T,(O)]+~v,,,Vr K4) 
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and the solution to (C4) is 
and A, and A, determined from the initial conditions of are: 
(C7) 
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